Blue Fin Capital, Inc. Gilead Sciences, Inc. Transaction History

Blue Fin Capital, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2018 Nov 09, 2018	SELL	$71.28 - $78.92 $209,420 - $231,866	-2,938 Closed	0 $0
Q2 2018 Aug 06, 2018	SELL	$64.88 - $75.68 $42,172 - $49,192	-650 Reduced 18.12%	2,938 $208,000
Q1 2018 May 07, 2018	SELL	$72.84 - $88.8 $23,673 - $28,860	-325 Reduced 8.31%	3,588 $270,000
Q4 2017 Jan 26, 2018	SELL	$71.15 - $83.52 $147,636 - $173,304	-2,075 Reduced 34.65%	3,913 $280,000
Q3 2017 Oct 11, 2017	BUY	$72.11 - $85.47 $431,794 - $511,794	5,988	5,988 $485,000

1,885

8.71M

8.02M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $83.5B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Blue Fin Capital, Inc., based on Form 13F filings with the SEC.

Stay updated on Blue Fin Capital, Inc. with notifications on news.